AlveoliX AG

AlveoliX’ mission is to make organs-on-chips the new standard for preclinical decision-making and the leading alternative to animal experiments.
Our Organs-on-Chip are used to better predict human responses in preclinical drug development and to gain more insight into human biology. We offer equipment and consumables to run organs-on-chip experiments in your laboratory or provide services for drug safety and efficacy testing for discovery and preclinical phases.
We aim to accelerate drug development by replacing animal studies and want to decrease any potential risks for patients during clinical testing and after approval. In the future, we also hope to be able to develop individual and preventive therapy thanks to personalized medicine.